Greenwich LifeSciences Inc XNAS: GLSI
Greenwich LifeSciences Inc Live Share Price Today, Share Analysis and Chart
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...
Read More43,511 XNAS Volume
XNAS 22 May, 2025 4:00 PM (EDT)
Greenwich LifeSciences Inc Live Price Chart
Loading Fundamental data..
Loading data..